Introduction
Fusarium is regarded as one of the most important mycotoxigenic fungi genera. It is known to produce several classes of mycotoxins of which the trichothecenes are the most important based on occurrence. From this class of mycotoxins, type A trichothecenes are the more toxic subclass. T-2 toxin (T-2)is the most acute toxic mycotoxin of the type A trichothecenes. It is commonly found in cereals and several European surveys have reported T-2 incidences over 80% for certain cereals and maximum concentrations up to 2,406 µg/kg have been observed in naturally contaminated oats [1] [2] [3] [4] .
Poultry is considered to have a high exposure to T-2 as their diet is mainly cereal based.
Toxic effects in poultry include inhibition of protein, DNA and RNA synthesis, immunomodulation, gastro-intestinal cell lesions, organs and neural disturbances [5] . At subclinical levels decreased performance parameters can be observed [6] .
For broiler chickens, first adverse effects like mucosal damage in the oral cavity occur at a dose of 40 µg/kg body weight (bw) per day. For laying hens, a reduction of the egg production and hatchability were observed at doses of 120 µg/kg bw per day [6] . Based on these data the European Union has issued indicative levels for the sum of T-2 and HT-2 toxin (HT-2) in food and feed commodities, from above which investigations should be performed, certainly in case of repetitive findings [7, 8] . For poultry compound feed, the indicative level is set at 250 µg T-2 + HT-2/kg feed.
The indicative levels suggested by legislative authorities only take into account free mycotoxins, such as T-2 and HT-2. However, based on recent research this appears to be an incomplete approach, as additionally to free mycotoxins, food and feed is often cocontaminated with modified mycotoxins. For T-2, in planta glycosylation of the 3-hydroxyl group to T-2 toxin-β-glucoside (T2-G) could be an important contributor to modified forms based on recent studies. The occurrence of T2-G in naturally infected wheat and oats has been described by Lattanzio et al. (2011) . Based on High-Resolution Mass Spectrometry (HRMS) peak area ratios between glucoside derivatives and free T2 and HT-2 in naturally contaminated wheat and oats samples, amounts of glycosylated T-2 and HT-2 as high as 27% of their deglycosylated counterparts were demonstrated [9] . Furthermore, Busman et al. and Lattanzio et al. observed that glycosylation is not only part of a detoxification strategy by plants, but can also be a relevant route of fungal metabolism [10, 11] .
The European Food Safety Authority (EFSA) recently published a scientific opinion on modified mycotoxins. In this opinion the relative contribution of modified forms of T-2 to the occurrence of T-2 was calculated to be 10%. The risk of this T2-G contribution was assessed for humans and several animal species (pigs, ruminants, horses, poultry and dogs) where possible. The combined risk of T-2, HT-2 and their modified forms was found not to be of concern, except for the highest upperbound exposure for toddlers, with levels slightly exceeding the TDI. Furthermore, the risk assessment assumed that all modified forms have the same toxicity as their parent compounds, and this due to the lack of information on bioavailability and toxicity of these modified forms [1] . However, as shown by several studies, modified mycotoxins may have a significantly altered inert toxicity and oral bioavailability; in addition they may be subject to in vivo hydrolysis as well [12] [13] [14] . These knowledge gaps pose an additional uncertainty on the derived conclusions of this scientific opinion.
Presently, no toxicokinetic data is available for T2-G in humans nor animals.
Determination of the absolute oral bioavailability, in vivo hydrolysis and toxicokinetic characteristics could significantly contribute to an accurate risk assessment by legislative authorities on modified mycotoxins such as T2-G.
Experimental

Compounds, standards and solutions
T-2, HT-2 and T-2 triol were purchased from Fermentek (Jerusalem, Israel). T2-G was synthesized by the United States Department of Agriculture (USDA) as described [15] . All 
Instrumentation, materials & reagents
Separation of analytes was achieved on an Acquity UPLC ® BEH C18 column (150 x 2.1 mm i.d., 1.7 μm) with an Acquity UPLC ® BEH C18 column VanGuard pre-column (5 x 2.1 mm i.d., 1.7 µm). An Acquity UPLC system coupled to a Xevo ® TQ-S mass spectrometer was used, operating in positive electrospray ionization (ESI + ) mode, all from Waters (Zellik, Belgium).
Microfilters Durapore PVDF (0.22 µm) were obtained from Millipore (Overijse, Belgium).
Water, methanol, acetic acid and ammonium acetate (all UHPLC grade) were purchased from Biosolve (Valkenswaard, The Netherlands). Acetonitrile (HPLC grade) was obtained from VWR (Leuven, Belgium).
Plasma sample preparation
Blank plasma samples. 
Incurred samples.
To 200 µL of plasma, 20 µL of a 100 ng/mL IS working solution were added and the samples were subjected to the same sample preparation procedure as the calibrator samples. product ions used for quantification and qualification, are given in Table 1 .
LC-MS/MS analysis
Validation
Validation was performed on spiked blank plasma samples. As validation guidelines recommendations by the European Community [17, 18] and the Veterinary International
Conference on Harmonisation (VICH) [19] were utilized.
Linearity of the response of the compounds was assessed by means of three matrixmatched calibration curves consisting of at least seven calibration points in the range of 0.1-criteria and corresponding acceptability ranges were correlation coefficients (r) ≥0.99 and goodness-of-fit coefficients (gof) ≤20%.
Within-day accuracy & precision were determined by analyzing six samples at a low concentration level (limit of quantitation or LOQ of the analytes) and at a high concentration level (range maximum). Values for the relative standard deviation (RSD) should not exceed 2/3 of the RSDmax, calculated according to the Horwitz equation [20] . The acceptance criteria for accuracy were: −50% to +20%, −30% to +10% and −20% to +10% for concentrations ≤ 0.1 ng/mL, between 1 and 10 ng/mL, and ≥10 ng/mL, respectively.
Between-day accuracy & precision were assessed by analyzing the LOQ and range maximum in threefold on three consecutive days (n=3x3). The acceptance criteria for accuracy were identical to the values given above and RSD values should not exceed the RSDmax [20] .
The LOQ was calculated as the lowest concentration for which the method had 
Animal trial
Six broilers (Ross 308, mixed sex, 18 days of age) were housed at the Faculty of 
Toxicokinetic modeling and statistical analysis
Toxicokinetic analysis was performed using WinNonlin Professional version 5. 
Results and discussion
The results for linearity, r and gof, sensitivity, LOD and LOQ, are given in Table 2 . The results for linearity were all in accordance with the acceptance criteria, with r ≥ 0.99 and gof ≤ 20%. LOD varied from 0.01 (T-2 triol), 0.02 (T-2 and T2-G) to 0.04 (HT-2) ng/mL. LOQ was 0.1 ng/mL for all mycotoxins. Table 3 displays the results for accuracy (%) and precision (RSD, %). All results fell within the specified acceptability ranges.
The method was specific as no interfering peaks were detected in the chromatographic elution zone of the analytes with S/N values ≥ 3 (results not shown).
Furthermore, carry-over was evaluated (results not shown). For none of the compounds signals were detected that could interfere with the response/area of the analytes at their given retention time.
In preliminary studies administered doses calculated based on EU maximum guidance values in feed could not be detected in plasma of broilers after PO administration [22] . [23] . In contrast, the values for these toxicokinetics parameters described by Osselaere et al. differ significantly, this discrepancy is probably caused by the application of a non-compartmental model [22] .
For T2-G a FRAC and F of 10.4±8.7% and 10.1±8.5% were determined, respectively.
This slight difference is caused by a partial presystemic hydrolysis, 3.85±1.31%, of T2-G to T-2. The FRAC of T2-G is five times higher than that of T-2. Mean T2-G volumes of distribution, CL and Cmax values were significantly larger than those observed for T-2. Mean values for β (0.0285/min) and t1/2β (24.3 min) of T2-G do not significantly differ from those obtained for T-2.
These differences in toxicokinetics parameters between T-2 and T2-G, specifically the five times higher FRAC for T2-G, clearly indicate the flaw in assuming equal toxicity of modified and parent compounds in risk assessment [1] . For every amount of T2-G in feed, compared to T-2, the systemic exposure to the glucoside conjugate will be five times higher.
Consequently, the contribution in feed, estimated at 10% would result in an in vivo contribution of 50%. This clearly indicates the flaw in assuming equal toxicity of modified and parent compounds in risk assessment.
Assuming equal intrinsic toxicity is similarly flawed. Although no T2-G toxicity data is available, a clearly decreased toxicity has been demonstrated for deoxynivalenol-3-glucoside (DON3G) compared to DON [21, [24] [25] [26] . Given the high degree of structural similarity between DON and T-2, a similar decrease in toxicity may reasonably be expected for T2-G.
Furthermore, as seen with DON3G, T2-G was not hydrolysed in broiler chickens to its respective free mycotoxin in a significant extent. Consequently, although a relatively higher oral bioavailability and absorbed fraction were observed, further research is needed as the contribution of these modified forms to the overall toxicity of these mycotoxins may be limited due to a probable low intrinsic toxicity as well as absence of a significant degree of hydrolysis. Values are presented as mean ± SD. ke=elimination rate constant (1/min); t1/2el=elimination half-live (min); CL=clearance (mL/min/kg); Vc=central volume of distribution (mL/kg); Vp=peripheral volume of distribution (mL/kg); FRAC=absorbed fraction (%);
Pres.Hydr.=percentage of the total dose that is hydrolysed presystemically (%); F=absolute oral bioavailability (%); Cmax=maximum plasma concentration (ng/mL); tmax= time to maximum plasma concentration (min); Statistical analysis was performed by means of ANOVA,* statistically significant difference (p<0.05)
